How neutrophils kill microbes

Annual Review of Immunology

Volumn 23, Issue , 2005, Pages 197-223

  Segal, Anthony W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bacteria; Enzyme; Free radical; Ion channel; Microbicidal; Protease

Indexed keywords

CATHEPSIN G; FREE RADICAL; GELATINASE; GLYCOPROTEIN GP 91; HALIDE; ION CHANNEL; MYELOPEROXIDASE; NITRIC OXIDE; POTASSIUM CHANNEL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

BACTERIUM; CELL GRANULE; CELL KILLING; CELL MEMBRANE; CELL VACUOLE; FUNGUS; GRANULOMATOSIS; HALOGENATION; HUMAN; IMMUNITY; INNATE IMMUNITY; LEUKOCYTE FUNCTION; LYSOSOME; MICROORGANISM; MOLECULAR GENETICS; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESPIRATORY CHAIN; REVIEW;

ANIMALS; ELECTRON TRANSPORT; HUMANS; IMMUNITY, NATURAL; MICROSCOPY, ELECTRON; MODELS, IMMUNOLOGICAL; NADPH OXIDASE; NEUTROPHILS; PHAGOCYTOSIS; REACTIVE OXYGEN SPECIES; VACUOLES;

EID: 17644377258     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.23.021704.115653     Document Type: Review

References (126)

1. Cohn ZA, Hirsch JG. 1960. The influence of phagocytosis on the intracellular distribution of granule-associated components of polymorphonuclear leucocytes. J. Exp. Med. 112:1015-22
2. Iyer GYN, Islam DMF, Quastel JH. 1961. Biochemical aspects of phagocytosis. Nature 192:535-41
3. Holmes B, Page AR, Good RA. 1967. Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocyte function. J. Clin. Invest. 46:1422-32
4. Klebanoff SJ, White LR. 1969. Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood. N. Engl. J. Med. 280:460-66
5. Babior BM, Kipnes RS, Curnutte JT. 1973. Biological defence mechanisms: the production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 52:741-44
6. + flux. Nature 416:291-97
7. Vento S, Cainelli F. 2003. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol. 4:595-604
8. Winkelstein JA, Marino MC, Johnston RBJ, Boyle J, Curnutte J, et al. 2000. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-69
9. Segal AW, Harper AM, Garcia RC, Merzbach D. 1982. The action of cells from patients with chronic granulomatous disease on Staphylococcus aureus. J. Med. Microbiol. 15:441-49
10. Thrasher AJ, Keep NH, Wientjes F, Segal AW. 1994. Chronic granulomatous disease. Biochim. Biophys. Acta 1227:1-24
11. Mandell GL. 1974. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect. Immun. 9:337-41
12. Cross AR, Segal AW. 2004. The NADPH oxidase of professional phagocytes-prototype of the NOX electron transport chain systems. Biochem. Biophysica Acta-Bioenergetics 1657:1-22
13. Vignais PV. 2002. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell. Mol. Life Sci. 59:1428-59
14. -245 β-chain. Protein Sci. 2:1675-85
15. Wientjes FB, Segal AW. 2003. PX domain takes shape. Curr. Opin. Hematol. 10:2-7
16. Lew PD, Southwick FS, Stossel TP, Whitin JC, Simons E, Cohen HJ. 1981. A variant of chronic granulomatous disease: deficient oxidative metabolism due to a low-affinity NADPH oxidase. N. Engl. J. Med. 305:1329-33
17. Segal AW, Dorling J, Coade S. 1980. Kinetics of fusion of the cytoplasmic granules with phagocytic vacuoles in human polymorphonuclear leukocytes. Biochemical and morphological studies. J. Cell Biol. 85:42-59
18. Briggs RT, Robinson JM, Karnovsky ML, Karnovsky MJ. 1986. Superoxide production by polymorphonuclear leukocytes. A cytochemical approach. Histochemistry 84:371-78
19. Segal AW, Meshulam T. 1979. Production of superoxide by neutrophils: a reappraisal. FEBS Lett. 100:27-32
20. Thomas MJ, Hedrick CC, Smith S, Pang J, Jerome WG, et al. 1992. Superoxide generation by the human polymorphonuclear leukocyte in response to latex beads. J. Leukoc. Biol. 51:591-96
21. McCord JM, Fridovich I. 1969. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:6049-55
22. Hampton MB, Kettle AJ, Winterbourn CC. 1998. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92:3007-17
23. Halliwell B, Gutteridge JMC. 1999. Free Radicals in Biology and Medicine. New York: Oxford Univ. Press
24. Babior BM, Curnutte JT, Kipnes RS. 1975. Biological defense mechanisms. Evidence for the participation of superoxide in bacterial killing by xanthine oxidase. J. Lab. Clin. Med. 85:235-44
25. Rosen H, Klebanoff SJ. 1979. Bactericidal activity of a superoxide anion-generating system. A model for the polymorphonuclear leukocyte. J. Exp. Med. 149:27-39
26. Ambruso DR, Johnston RB Jr. 1981. Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil paniculate fractions, and an enzymatic generating system. J. Clin. Invest. 67:352-60
27. Rosen H. 1980. Role of hydroxyl radical in polymorphonuclear leukocyte-mediated bactericidal activity. Agents Actions Suppl. 7:180-84
28. Cohen MS, Britigan BE, Pou S, Rosen GM. 1991. Application of spin trapping to human phagocytic cells: insight into conditions for formation and limitation of hydroxyl radical. Free Radic. Res. Commun. 12-13(Pt. 1):17-25
29. Gutteridge JM, Paterson SK, Segal AW, Halliwell B. 1981. Inhibition of lipid peroxidation by the iron-binding protein lactoferrin. Biochem. J. 199:259-61
30. Winterbourn CC. 1983. Lactoferrin-catalysed hydroxyl radical production. Additional requirement for a chelating agent. Biochem. J. 210:15-19
31. Britigan BE, Hassett DJ, Rosen GM, Hamill DR, Cohen MS. 1989. Neutrophil degranulation inhibits potential hydroxyl-radical formation. Relative impact of myeloperoxidase and lactoferrin release on hydroxyl-radical production by iron-supplemented neutrophils assessed by spin-trapping techniques. Biochem. J. 264:447-55
32. Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE. 1995. Free radicals and phagocytic cells. FASEB J. 9:200-9
33. Banerjee R, Ragsdale SW. 2003. The many faces of vitamin B12: catalysis by cobalamin-dependent enzymes. Annu. Rev. Biochem. 72:209-47
34. Wentworth P Jr, McDunn JE, Wentworth AD, Takeuchi C, Nieva J, et al. 2002. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 298:2195-99
35. Babior BM, Takeuchi C, Ruedi J, Gutierrez A, Wentworth P Jr. 2003. Investigating antibody-catalyzed ozone generation by human neutrophils. Proc. Natl. Acad. Sci. USA 100:3031-34
36. Kettle AJ, Clark BM, Winterbourn CC. 2004. Superoxide converts indigo carmine to isatin sulfonic acid: implications for the hypothesis that neutrophils produce ozone. J. Biol. Chem. 279:18521-25
37. Fiedler TJ, Davey CA, Fenna RE. 2000. X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 Å resolution. J. Biol. Chem. 275:11964-71
38. Klebanoff SJ. 1968. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J. Bacteriol. 95:2131-38
39. Klebanoff SJ. 1975. Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin. Hematol. 12:117-42
40. Klebanoff SJ. 1967. Iodination of bacteria: a bactericidal mechanism. J. Exp. Med. 126:1063-78
41. Hampton MB, Kettle AJ, Winterbourn CC. 1996. Involvement of superoxide and myeloperoxidase in oxygen-dependent killing of Staphylococcus aureus by neutrophils. Infect. Immun. 64:3512-17
42. Lehrer RI, Hanifin J, Cline MJ. 1969. Defective bactericidal activity in myeloperoxidase-deficient human neutrophils. Nature 223:78-79
43. Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, et al. 2000. Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase. J. Infect. Dis. 182:1276-79
44. Gaut JP, Yeh GC, Tran HD, Byun J, Henderson JP, et al. 2001. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc. Natl. Acad. Sci. USA 98:11961-66
45. Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, Maeda N. 1999. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect. Immun. 67:1828-36
46. Wheeler MA, Smith SD, Garcia-Cardena G, Nathan CF, Weiss RM, Sessa WC. 1997. Bacterial infection induces nitric oxide synthase in human neutrophils. J. Clin. Invest. 99:110-16
47. Chakravortty D, Hensel M. 2003. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes. Infect. 5:621-27
48. Fleming A. 1922. On a remarkable bacteriolytic element found in tissues and secretions. Proc. R. Soc. London 93:306-317
49. Hirsch JG. 1956. Phagocytin: a bactericidal substance from polymorphonuclear leucocytes. J. Exp. Med. 103:589-611
50. Zeya HI, Spitznagel JK. 1968. Arginine-rich proteins of polymorphonuclear leukocyte lysosomes. Antimicrobial specificity and biochemical heterogeneity. J. Exp. Med. 127:927-41
51. Borregaard N, Cowland JB. 1997. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503-21
52. Gullberg U, Bengtsson N, Bulow E, Garwicz D, Lindmark A, Olsson I. 1999. Processing and targeting of granule proteins in human neutrophils. J. Immunol. Methods 232:201-10
53. Bainton DF. 1993. Neutrophilic leukocyte granules: from structure to function. Adv. Exp. Med. Biol. 336:17-33
54. Baggiolini M, Hirsch JG, De Duve C. 1969. Resolution of granules from rabbit heterophil leukocytes into distinct populations by zonal sedimentation. J. Cell Biol. 40:529-41
55. Weiss J, Franson RC, Beckerdite S, Schmeidler K, Elsbach P. 1975. Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli. J. Clin. Invest. 55:33-42
56. Weiss J, Elsbach P, Olsson I, Odeberg H. 1978. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J. Biol. Chem. 253:2664-72
57. Ooi CE, Weiss J, Doerfler ME, Elsbach P. 1991. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/ permeability-increasing protein of human neutrophils. J. Exp. Med. 174:649-55
58. Ganz T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3:710-20
59. Kolset SO, Gallagher JT. 1990. Proteoglycans in haemopoietic cells. Biochim. Biophys. Acta 1032:191-211
60. Styrt B, Klempner MS. 1982. Internal pH of human neutrophil lysosomes. FEBS Lett. 149:113-16
61. Bullen JJ, Armstrong JA. 1979. The role of lactoferrin in the bactericidal function of polymorphonuclear leucocytes. Immunology 36:781-91
62. Bundgaard JR, Sengelov H, Borregaard N, Kjeldsen L. 1994. Molecular cloning and expression of a cDNA encoding NGAL: a lipocalin expressed in human neutrophils. Biochem. Biophys. Res. Commun. 202:1468-75
63. Segal AW, Jones OT. 1979. The subcellular distribution and some properties of the cytochrome b component of the microbicidal oxidase system of human neutrophils. Biochem. J. 182:181-88
64. Hibbs MS, Bainton DF. 1989. Human neutrophil gelatinase is a component of specific granules. J. Clin. Invest 84:1395-402
65. Borregaard N, Kjeldsen L, Rygaard K, Bastholm L, Nielsen MH, et al. 1992. Stimulus-dependent secretion of plasma proteins from human neutrophils. J. Clin. Invest. 90:86-96
66. Baggiolini M, Hirsch JG, De Duve C. 1970. Further biochemical and morphological studies of granule fractions from rabbit heterophil leukocytes. J. Cell Biol. 45:586-97
67. Sengelov H, Kjeldsen L, Kroeze W, Berger M, Borregaard N. 1994. Secretory vesicles are the intracellular reservoir of complement receptor 1 in human neutrophils. J. Immunol. 153:804-10
68. Segal AW, Geisow M, Garcia R, Harper A, Miller R. 1981. The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH. Nature 290:406-9
69. Holmes B, Quie PG, Windhorst DB, Good RA. 1966. Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet 1:1225-28
70. Wright SD, Silverstein SC. 1984. Phagocytosing macrophages exclude proteins from the zones of contact with opsonized targets. Nature 309:359-61
71. Bainton DF. 1973. Sequential degranulation of the two types of polymorphonuclear leukocyte granules during phagocytosis of microorganisms. J. Cell Biol. 58:249-64
72. Jensen MS, Bainton DF. 1973. Temporal changes in pH within the phagocytic vacuole of the polymorphonuclear neutrophilic leukocyte. J. Cell Biol. 56:379-88
73. Cech P, Lehrer RI. 1984. Phagolysosomal pH of human neutrophils. Blood 63:88-95
74. + channel is essential for innate immunity. Nature 427:853-58
75. Belaaouaj A, McCarthy R, Baumann M, Gao Z, Ley TJ, et al. 1998. Mice lacking neutrophil elastase reveal impaired host defense against Gram negative bacterial sepsis. Nat. Med. 4:615-18
76. Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J. 2000. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12:201-10
77. MacIvor DM, Shapiro SD, Pham CT, Belaaouaj A, Abraham SN, Ley TJ. 1999. Normal neutrophil function in cathepsin G-deficient mice. Blood 94:4282-93
78. + channel. Biochem. J. 246:325-29
79. +-conducting pathway in the membrane of neutrophils. Biochem. J. 281:697-701
80. DeCoursey TE, Cherny VV. 1993. Potential, pH, and arachidonate gate hydrogen ion currents in human neutrophils. Biophys. J. 65:1590-98
81. Schrenzel J, Serrander L, Banfi B, Nusse O, Fouyouzi R, et al. 1998. Electron currents generated by the human phagocyte NADPH oxidase. Nature 392:734-37
82. Pauly H, Packer L, Schwan HP. 1960. Electrical properties of mitochondrial membranes. J. Biophys. Biochem. Cytol. 7:589-601
83. DeCoursey TE, Morgan D, Cherny VV. 2003. The voltage dependence of NADPH oxidase reveals why phagocytes need proton channels. Nature 422:531-34
84. Sanchez M, McManus OB. 1996. Paxilline inhibition of the alpha-subunit of the high-conductance calcium-activated potassium channel. Neuropharmacology 35:963-68
85. Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, et al. 1990. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J. Biol. Chem. 265:11083-90
86. Lawson K. 2000. Potassium channel openers as potential therapeutic weapons in ion channel disease. Kidney Int. 57:838-45
87. Kaczorowski GJ, Knaus HG, Leonard RJ, McManus OB, Garcia ML. 1996. High-conductance calcium-activated potassium channels; structure, pharmacology, and function. J. Bioenerg. Biomembr. 28:255-67
88. Jankowski A, Grinstein S. 1999. A non-invasive fluorimetric procedure for measurement of membrane potential. Quantification of the NADPH oxidase-induced depolarization in activated neutrophils. J. Biol. Chem. 274:26098-104
89. Borregaard N, Schwartz JH, Tauber AI. 1984. Proton secretion by stimulated neutrophils. Significance of hexose monophosphate shunt activity as source of electrons and protons for the respiratory burst. J. Clin. Invest. 74:455-59
90. Nanda A, Gukovskaya A, Tseng J, Grinstein S. 1992. Activation of vacuolar-type proton pumps by protein kinase C. Role in neutrophil pH regulation. J. Biol. Chem. 267:22740-46
91. Takanaka K, O'Brien PJ. 1988. Proton release associated with respiratory burst of polymorphonuclear leukocytes. J. Biochem. (Tokyo) 103:656-60
92. van Zwieten R, Wever R, Hamers MN, Weening RS, Roos D. 1981. Extracellular proton release by stimulated neutrophils. J. Clin. Invest. 68:310-13
93. + exchange in human neutrophils. II. Intracellular pH changes. J. Biol. Chem. 260:13248-55
94. Grinstein S, Furuya W. 1986. Cytoplasmic pH regulation in phorbol ester-activated human neutrophils. Am. J. Physiol. 251(Pt. 1):C55-65
95. + conducting channel. Biochem. J. 251:563-67
96. + (equivalent) conductance in the plasma membrane of human neutrophils. Proc. Natl. Acad. Sci. USA 88:10816-20
97. Henderson LM, Chappell JB, Jones OT. 1988. Superoxide generation by the electrogenic NADPH oxidase of human neutrophils is limited by the movement of a compensating charge. Biochem. J. 255:285-90
98. phox component of NADPH oxidase is not a voltage-gated proton channel. J. Gen. Physiol. 120:773-79
99. + pathway. J. Gen. Physiol. 114:771-86
100. phox modulate proton conduction by the phagocyte NADPH oxidase. J. Biol. Chem. 276:30277-84
101. + conductance of leukocytes. J. Biol. Chem. 269:27280-85
102. Thomas RC, Meech RW. 1982. Hydrogen ion currents and intracellular pH in depolarized voltage-clamped snail neurones. Nature 299:826-28
103. + conducting channel. Biochem. J. 251:563-67
104. DeCoursey TE. 2004. During the respiratory burst, do phagocytes need proton channels or potassium channels, or both? Sci. STKE 2004:E21
105. Miyasaki KT, Genco RJ, Wilson ME. 1986. Antimicrobial properties of hydrogen peroxide and sodium bicarbonate individually and in combination against selected oral, gram-negative, facultative bacteria. J. Dent. Res. 65:1142-48
106. Locksley RM, Wilson CB, Klebanoff SJ. 1983. Increased respiratory burst in myeloperoxidase-deficient monocytes. Blood 62:902-9
107. Clifford DP, Repine JE. 1982. Hydrogen peroxide mediated killing of bacteria. Mol. Cell Biochem. 49:143-49
108. Gallin JI, Buescher ES, Seligmann BE, Nath J, Gaither T, Katz P. 1983. NIH conference. Recent advances in chronic granulomatous disease. Ann. Intern. Med. 99:657-74
109. Holmes B, Good RA. 1972. Laboratory models of chronic granulomatous disease. J. Reticuloendothel. Soc. 12:216-37
110. Pitt J, Bernheimer HP. 1974. Role of peroxide in phagocytic killing of pneumococci. Infect. Immun. 9:48-52
111. Mandell GL. 1975. Catalase, superoxide dismutase, and virulence of Staphylococcus aureus. In vitro and in vivo studies with emphasis on staphylococcal-leukocyte interaction. J. Clin. Invest. 55:561-66
112. phox-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease. J. Clin. Invest. 101:1843-50
113. Messina CG, Reeves EP, Roes J, Segal AW. 2002. Catalase negative Staphylococcus aureus retain virulence in mouse model of chronic granulomatous disease. FEBS Lett. 518:107-10
114. Ismail G, Boxer LA, Baehner RL. 1979. Utilization of liposomes for correction of the metabolic and bactericidal deficiencies in chronic granulomatous disease. Pediatr. Res. 13:769-73
115. Gerber CE, Bruchelt G, Falk UB, Kimpfler A, Hauschild O, et al. 2001. Reconstitution of bactericidal activity in chronic granulomatous disease cells by glucose-oxidase-containing liposomes. Blood 98:3097-105
116. Reeves EP, Nagl M, Godovac-Zimmermann J, Segal AW. 2003. Reassessment of the microbicidal activity of reactive oxygen species and hypochlorous acid with reference to the phagocytic vacuole of the neutrophil granulocyte. J. Med. Microbiol. 52:643-51
117. Deleted in proof
118. Klebanoff SJ, Clark RA. 1977. Iodination by human polymorphonuclear leukocytes: a re-evaluation. J. Lab. Clin. Med. 89:675-86
119. Segal AW, Garcia RC, Harper AM, Banga JP. 1983. Iodination by stimulated human neutrophils. Studies on its stoichiometry, subcellular localization and relevance to microbial killing. Biochem. J. 210:215-25
120. Chapman AL, Hampton MB, Senthilmohan R, Winterbourn CC, Kettle AJ. 2002. Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus. J. Biol. Chem. 277:9757-62
121. Nauseef WM. 1988. Myeloperoxidase deficiency. Hematol. Oncol. Clin. N. Am. 2:135-58
122. Penniall R, Spitznagel JK. 1975. Chicken neutrophils: oxidative metabolism in phagocytic cells devoid of myeloperoxidase. Proc. Natl. Acad. Sci. USA 72:5012-15
123. 2-halide system. J. Lab. Clin. Med. 100:896-907
124. Kettle AJ, Winterbourn CC. 2001. A kinetic analysis of the catalase activity of myeloperoxidase. Biochemistry 40:10204-12
125. Winterbourn CC, Garcia RC, Segal AW. 1985. Production of the superoxide adduct of myeloperoxidase (compound III) by stimulated human neutrophils and its reactivity with hydrogen peroxide and chloride. Biochem. J. 228:583-92
126. Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, et al. 2002. Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans. J. Infect. Dis. 185:1833-37